Mir145 expression was downregulated ~6-fold in ATF3-induced mammary tumors (Figure 4A and Supplementary Table S1), consistent with its downregulation in human breast cancers [33,34,35], including basal-like [36] and triple-negative [37] breast cancers. Here, MIR145 is linked to breast carcinoma.